Top of page
Lawyers

Valentin Van de Walle

Lawyers

Filters

All practices...
Capital Markets
Convertible & Hybrid Securities
Equity: Post-IPO
High-Yield Debt
Investment-Grade Debt
IPOs & Direct Listings
Corporate
Environmental
ESG Risk
Executive Compensation
Finance
Financial Institutions
Financial Institutions Capital Markets
Investment Management
IP & Commercial Transactions
Public Company Advisory
Restructuring
Creditor & Ad Hoc Group Restructuring Matters
Tax
Transactional Tax Advice
All industries...
Cleantech
Consumer Products & Retail
Energy, Power & Infrastructure
Fintech & Cryptocurrency
Healthcare & Life Sciences
Industrials
Tech, Media & Telecom
All regions...
Asia
China
Japan
Europe
Latin America
Ascentage Pharma $126.4 million IPO
The IPO is the first life sciences U.S. IPO of 2025 and the first life sciences company listed on the HKEX to complete a U.S. listing
Back to top